This fellowship aims to develop, tailor and target the delivery of a 6-week group intervention that offers educational, psychological and social support for people following TIA and minor stroke.
The story of Martin, who had a stroke on Christmas day in 2009.
We want to explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used with people with aphasia. We also want to collect information to help us design a future large-scale trial evaluating this approach. SFBT is a ‘talking therapy’, which explores a person’s strengths and resilience to help build positive change in their lives.
At this week's UK Assembly North event in Nottingham, we heard from two eminent figures from the stroke research community. Professor Avril Drummond spoke about research into fatigue after stroke. Professor Joanna Wardlaw CBE spoke about the link between stroke and 'vascular dementia'.
The UK Stroke Assembly North took place on 30-31 May 2017 at Crewe Hall, Cheshire. Over 150 people affected by stroke came together to take action and have their say on stroke and aphasia. Read about the event, view photos and presentations from the plenary talks and workshops.
The UK Stroke Assembly South took place on 3-4 July 2017 at the Radisson Blu Stansted, Essex. Over 160 people affected by stroke came together to take action and have their say on stroke and aphasia. Read about the event, view photos and presentations from the plenary talks and workshops.
Published in the JNNP (Journal of Neurology, Neurosurgery and Psychiatry), new research suggests that a computer technique could help predict how well stroke survivors respond to language therapies for aphasia.
The aim of this research programme is to develop a human brain bank to support biomedical research into the pathophysiology of human SVD that may be used nationally and internationally.
The UK Stroke Assembly South was held on 3-4 July at the Radisson Blu Hotel, Stansted Airport. It was another great success, with over 160 people
attending over the two days.
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.